MAOB and Parkinson disease: MAO-B inhibition is therapeutically used for the treatment of neurodegenerative disorders, e.g., Alzheimer’s or Parkinson’s disease, whereby the reduced production of H2O2 during MAO-catalyzed oxidation of monoamine neurotransmitters may be decisive [48].